Cortexyme competitorsClear all
Cortexyme's top competitors include Alector, Aimmune Therapeutics and Repligen.
| Save Comparison |  Cortexyme Cortexyme is a biopharmaceutical company developing therapeutics for Alzheimer's disease and other degenerative disorders. |  Alector Alector is a clinical-stage biopharmaceutical company that develops therapies for the treatment of neurodegenerative diseases. |  Aimmune Therapeutics Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other food allergies. |  Repligen Repligen is a biopharmaceutical company that develops consumable products for the manufacture of biological drugs. |
Founding Date | Founding Date 2012 | Founding Date 2013 | Founding Date 2011 | Founding Date 1981 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations San Francisco, US HQ | Locations South San Francisco, US HQ Milpitas, US | Locations Brisbane, US HQ München, DE Dublin, IE London, GB Durham, US | Locations Waltham, US HQ Shanghai, CN Ravensburg, DE Bengaluru, IN Ritto, JP Seongnam Si, KR Breda, NL see more |
Employees | Employees 2321% increase | Employees 1264% increase | Employees 2755% increase | Employees 76139% increase |
Valuation ($) | Valuation ($) 961.9 m | Valuation ($) 1.3 b | Valuation ($) 2.3 b | Valuation ($) 11.8 b |
Twitter followers | Twitter followers 311 | Twitter followers N/A | Twitter followers 1.6 k | Twitter followers 182 |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 2 | Number of tweets (last 30 days) 4 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 18 | Average likes per tweet (last 30 days) 0.5 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 50% |
Alexa Website Rank | Alexa Website Rank 427855 | Alexa Website Rank 302916 | Alexa Website Rank 193253 | Alexa Website Rank 353570 |
Employee Rating | Employee Rating N/A | Employee Rating N/A | Employee Rating 4.3 | Employee Rating 2.5 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $21.2m (FY, 2019) | Revenue (est.) N/A | Revenue (est.) $270.2m (FY, 2019) |
Net income | Net income ($37m) (FY, 2019) | Net income ($105.4m) (FY, 2019) | Net income ($248.5m) (FY, 2019) | Net income $21.4m (FY, 2019) |
Operating ⚠ | ||||
Patent Applications | Patent Applications N/A | Patent Applications 190 (FY, 2019) | Patent Applications N/A | Patent Applications 106 (FY, 2019) |
Patents Issued | Patents Issued N/A | Patents Issued N/A | Patents Issued 2 (FY, 2016) | Patents Issued 52 (FY, 2019) |
Funding | ||||
Total funding raised | Total funding raised $ 100m | Total funding raised $ 194.5m | Total funding raised $ 145m | Total funding raised $ 4m |
For sources of this data, please see the company profile
View company profiles
Alector
HQ
South San Francisco, US
Employees
126↑ 4% increase
Alector is a clinical-stage biopharmaceutical company that develops therapies for the treatment of neurodegenerative diseases.
View companyAimmune Therapeutics
HQ
Brisbane, US
Employees
275↑ 5% increase
Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other food allergies.
View companyRepligen
HQ
Waltham, US
Employees
761↑ 39% increase
Repligen is a biopharmaceutical company that develops consumable products for the manufacture of biological drugs.
View company